Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT02493049 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Domperidone

Sponsor

University of Calgary

Collaborators

[object Object]